Surgical and post-operative treatment of chronic thromboembolic pulmonary hypertension

Patients with chronic thromboembolic pulmonary hypertension (CTEPH) have fibrous obstructions in their proximal pulmonary arteries, as well as a variable degree of secondary vascular remodelling of distal, surgically inaccessible, small pulmonary vessels. Pulmonary endarterectomy (PEA) is currently...

Full description

Bibliographic Details
Main Author: E. Mayer
Format: Article
Language:English
Published: European Respiratory Society 2010-03-01
Series:European Respiratory Review
Subjects:
Online Access:http://err.ersjournals.com/cgi/content/full/19/115/64
id doaj-38bfc48dbd014f0382af029e72253d2b
record_format Article
spelling doaj-38bfc48dbd014f0382af029e72253d2b2020-11-25T02:37:05ZengEuropean Respiratory SocietyEuropean Respiratory Review0905-91801600-06172010-03-01191156467Surgical and post-operative treatment of chronic thromboembolic pulmonary hypertensionE. MayerPatients with chronic thromboembolic pulmonary hypertension (CTEPH) have fibrous obstructions in their proximal pulmonary arteries, as well as a variable degree of secondary vascular remodelling of distal, surgically inaccessible, small pulmonary vessels. Pulmonary endarterectomy (PEA) is currently the only potentially curative treatment option for CTEPH, although it is not known whether it has a beneficial effect on established secondary remodelling. Medical pre-treatment with therapies specific for pulmonary hypertension is often used as a bridge to PEA. The aim of PEA is the mechanical removal of the proximal fibrous pulmonary artery obstruction as completely as possible while avoiding vascular injury within the lung. The challenge is to find and follow the correct pulmonary artery endarterectomy plane in the time allowed during brief periods of circulatory arrest. Learning the operative technique is a complex process and, thus, early mortality after PEA decreases with increasing levels of surgical training and experience. Most patients experience lasting symptomatic and haemodynamic improvements after PEA, with only 10–20% having persistent or recurrent pulmonary hypertension after surgery. http://err.ersjournals.com/cgi/content/full/19/115/64Chronic thromboembolic pulmonary hypertensionhaemodynamicspulmonary endarterectomypulmonary hypertensionpulmonary vascular resistance
collection DOAJ
language English
format Article
sources DOAJ
author E. Mayer
spellingShingle E. Mayer
Surgical and post-operative treatment of chronic thromboembolic pulmonary hypertension
European Respiratory Review
Chronic thromboembolic pulmonary hypertension
haemodynamics
pulmonary endarterectomy
pulmonary hypertension
pulmonary vascular resistance
author_facet E. Mayer
author_sort E. Mayer
title Surgical and post-operative treatment of chronic thromboembolic pulmonary hypertension
title_short Surgical and post-operative treatment of chronic thromboembolic pulmonary hypertension
title_full Surgical and post-operative treatment of chronic thromboembolic pulmonary hypertension
title_fullStr Surgical and post-operative treatment of chronic thromboembolic pulmonary hypertension
title_full_unstemmed Surgical and post-operative treatment of chronic thromboembolic pulmonary hypertension
title_sort surgical and post-operative treatment of chronic thromboembolic pulmonary hypertension
publisher European Respiratory Society
series European Respiratory Review
issn 0905-9180
1600-0617
publishDate 2010-03-01
description Patients with chronic thromboembolic pulmonary hypertension (CTEPH) have fibrous obstructions in their proximal pulmonary arteries, as well as a variable degree of secondary vascular remodelling of distal, surgically inaccessible, small pulmonary vessels. Pulmonary endarterectomy (PEA) is currently the only potentially curative treatment option for CTEPH, although it is not known whether it has a beneficial effect on established secondary remodelling. Medical pre-treatment with therapies specific for pulmonary hypertension is often used as a bridge to PEA. The aim of PEA is the mechanical removal of the proximal fibrous pulmonary artery obstruction as completely as possible while avoiding vascular injury within the lung. The challenge is to find and follow the correct pulmonary artery endarterectomy plane in the time allowed during brief periods of circulatory arrest. Learning the operative technique is a complex process and, thus, early mortality after PEA decreases with increasing levels of surgical training and experience. Most patients experience lasting symptomatic and haemodynamic improvements after PEA, with only 10–20% having persistent or recurrent pulmonary hypertension after surgery.
topic Chronic thromboembolic pulmonary hypertension
haemodynamics
pulmonary endarterectomy
pulmonary hypertension
pulmonary vascular resistance
url http://err.ersjournals.com/cgi/content/full/19/115/64
work_keys_str_mv AT emayer surgicalandpostoperativetreatmentofchronicthromboembolicpulmonaryhypertension
_version_ 1724796759340744704